New HIV cocktail aims to rescue patients with advanced disease
NCT ID NCT00302822
First seen Apr 11, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study tested whether adding an extra drug, enfuvirtide, to standard HIV therapy for 6 months could help severely ill patients recover their immune systems faster. It included 195 adults with HIV who had very low CD4 counts or a recent AIDS diagnosis and had never taken HIV drugs before. The goal was to see if more patients could reach a safe CD4 level after 24 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service des Maladies Infectieuses A Hôpital Bichat-Claude Bernard
Paris, 75018, France
Conditions
Explore the condition pages connected to this study.